Result of General Meeting and £15m fundraise
Quantum Pharma Plc (AIM: QP.) the service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, announced on 20 October 2016 that the Company had raised a total of £15 million (before expenses) by means of an accelerated bookbuild with new and existing investors, of 44,117,647 Placing Shares at a price of 34 pence per share. The Placing was subject, inter alia, to the approval by Shareholders of certain resolutions set out in the Notice of General Meeting issued on 21 October 2016.
The Company is pleased to announce that at the General Meeting, which was held in Newcastle upon Tyne earlier today, all resolutions were duly passed.
An application has been made to the London Stock Exchange for the Placing Shares to be admitted to trading on AIM and it is expected that Admission will occur and that dealings will commence at 8.00 a.m. on 11 November 2016.
Upon Admission, the Company's issued share capital will comprise 169,117,640 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in treasury. Therefore, this figure of 169,117,640 Ordinary Shares may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Posted by: Quantum Webmaster on 10th November 2016